Teva Pharmaceutical Industries: Pay

Teva Pharmaceutical Industries paid its 5 named executives $45.5M in total in FY2025 (Dec). CEO Richard Francis was paid $19.2M of that.

PayNo stock prices for these years
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Richard FrancisPresident and Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)Not disclosed
FY2023 (Dec)Not disclosed
3 years
Evan LippmanExecutive Vice President, Business Development
FY2025 (Dec)
1 year
Eli KalifExecutive Vice President, Chief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Dr. Eric HughesExecutive Vice President, Global R&D and Chief Medical Officer
FY2025 (Dec)
FY2024 (Dec)
2 years
Christine FoxExecutive Vice President, US Commercial
FY2025 (Dec)
FY2024 (Dec)
2 years

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.